B-cell lymphoma 2 inhibitor venetoclax treatment of a patient with cutaneous T-cell lymphoma

door King, Amber Loren O., Mirza, Fatima N., Lewis, Julia M., Carlson, Kacie R., Huntington, Scott, Foss, Francine M., Girardi, Michael
Gepubliceerd in JAAD Case Rep (2020)

JAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCL

door Yumeen, Sara, Mirza, Fatima N., Lewis, Julia M., King, Amber Loren O., Kim, Sa Rang, Carlson, Kacie R., Umlauf, Sheila R., Surovtseva, Yulia V., Foss, Francine M., Girardi, Michael
Gepubliceerd in Blood Adv (2020)